Showing results (141-150 of 212) with videos related to

Sort By:
Pageof 22
Pancreas|June 17, 2020
Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic CancerDavid Goldstein, Daniel D Von Hoff, E Gabriela Chiorean, et al.
The Oncologist|January 14, 2015
Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancerJosep Tabernero, E Gabriela Chiorean, Jeffrey R Infante, et al.
The Oncologist|August 9, 2019
An Analysis of Patients with DNA Repair Pathway Mutations Treated with a PARP InhibitorErkut Borazanci, Ronald Korn, Winnie S Liang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2015
SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT TrialManuel Hidalgo, Carlos Plaza, Monica Musteanu, et al.
Cancer Biology & Therapy|October 7, 2008
Copy number alterations in pancreatic cancer identify recurrent PAK4 amplificationShuaili Chen, Theresa Auletta, Ostap Dovirak, et al.
British Journal of Cancer|June 29, 2016
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancerE Gabriela Chiorean, Daniel D Von Hoff, Josep Tabernero, et al.
Frontiers in Oncology|September 27, 2021
Role of 3D Volumetric and Perfusion Imaging for Detecting Early Changes in Pancreatic AdenocarcinomaSyed Rahmanuddin, Ronald Korn, Derek Cridebring, et al.
Cancer Research|July 12, 2022
Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAILRussell Moser, James Annis, Olga Nikolova, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2018
Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorinRichard A Hubner, Antonio Cubillo, Jean-Frédéric Blanc, et al.
British Journal of Cancer|September 2, 2025
Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinomaKuntal Halder, Erkut H Borazanci, Gayle S Jameson, et al.
Pageof 22